Market Research Report
Global Flow Cytometry Market - Segmented by Type of Product, Technology, Application, End User, and Geography - Growth, Trends, and Forecast (2018 - 2023)
|Published by||Mordor Intelligence LLP||Product code||390840|
|Published||Content info||105 Pages
Delivery time: 1-2 business days
|Global Flow Cytometry Market - Segmented by Type of Product, Technology, Application, End User, and Geography - Growth, Trends, and Forecast (2018 - 2023)|
|Published: April 1, 2018||Content info: 105 Pages||
The global flow cytometry market is expected to register a CAGR of 7.1% during 2018 to 2023 (the forecast period). Flow cytometry has evolved from a promising new technology to an indispensable tool, and its market is seeing a boom because of its application in the diagnosis of various disorders, like hematological disorders, malignancies, and various infections.
Use of Flow Cytometry in Stem Cell Research
Flow cytometry has been in use for decades by biologists studying hematopoietic stem cells to address the challenge of heterogeneity. New methods and tools are enabling researchers to employ this powerful technique to make key discoveries about other stem cell types and their respective lineages. Globally, the stem cell therapy market is expected to be worth USD 40 billion by 2020. Therefore, there is an expected potential for growth in the flow cytometry market for stem cell therapy in the coming years. Increase in funding from government and private organizations for stem cell research is also another factor that is expected to propel the market growth. Other factors, such as emergence and commercial application of new technologies in the field of flow cytometry and increasing applications of flow cytometry in clinical research, are increasing the growth of the market.
Expensive Equipment Hindering the Growth of the Market
Flow cytometers are expensive. The instrument cost can go as high as USD 350,000 depending on the parameters it can measure. The least expensive flow cytometers available now cost over USD 10,000 and measure to only two or three parameters. On top of that, assay reagent kits, filters, and other consumables add a few hundreds of dollars more to the overall expense. The expensive instrument and assay kits are hindering the growth of the flow cytometry market. Factors, such as lack of awareness about the potential benefits of flow cytometry techniques, are slowing the growth of the market.
United States to Lead the Market
The United States, in the North American region, dominates the market of flow cytometry due to the presence of supportive government policies for the development of advanced technologies for healthcare. North America is followed by Europe and Asia-Pacific. Asia-Pacific is expected to witness a lucrative growth rate during the forecast period.
Key Developments in the Market
January 2018 - Attune NxT Flow Cytometer system made multiparametric flow cytometry available to both new and experienced researchers.
January 2018 - Bio-Rad acquired RainDance Technologies.
Major Players: BECKMAN COULTER, BECTON DICKINSON, EMD MILLIPORE, LIFE TECHNOLOGIES, BIO-RAD LABORATORIES, MILTENYI BIOTECH, SYSMEX PARTEC GMBH, THERMO FISHER SCIENTIFIC INC., and LUMINEX CORPORATION, among others.
Reasons to Purchase this Report
Current and future flow cytometry market outlook in the developed and emerging markets
Analyzing various perspectives of the market with the help of Porter's five forces analysis
The segment that is expected to dominate the market
Regions that are expected to witness the fastest growth during the forecast period
Identify the latest developments, market shares, and strategies employed by the major market players
3 months analyst support, along with the Market Estimate sheet (in excel)
Customization of the Report
This report can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
List Not Exhaustive